Hanover, NH, United States of America

Dale Mierke

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Dartmouth College. Active years: 2012-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dale Mierke. Retrieved from https://idiyas.com/inventor/dale-mierke

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 67(Granted Patents)


Company Filing History:


Years Active: 2012-2015

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Dale Mierke: Innovator in Monocyclic Cyanoenones

Introduction

Dale Mierke is a notable inventor based in Hanover, NH (US). He has made significant contributions to the field of medicinal chemistry, particularly through his work on monocyclic cyanoenones. With a total of 2 patents, Mierke's innovations are aimed at addressing critical health issues.

Latest Patents

Mierke's latest patents focus on monocyclic cyanoenone compositions and their methods of use. These inventions are designed for the treatment of various diseases, including cancer, inflammatory diseases, and neurodegenerative diseases. The potential applications of these compositions could lead to significant advancements in therapeutic strategies.

Career Highlights

Dale Mierke is affiliated with Dartmouth College, where he conducts research and develops his innovative ideas. His work has garnered attention in the scientific community, contributing to the advancement of medical treatments.

Collaborations

Mierke collaborates with talented individuals such as Tadashi Honda and Emilie David, who contribute to his research efforts. Their combined expertise enhances the potential impact of Mierke's inventions.

Conclusion

Dale Mierke's contributions to the field of medicinal chemistry through his patents on monocyclic cyanoenones highlight his commitment to improving health outcomes. His work exemplifies the importance of innovation in addressing complex medical challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…